Ki-67 Index Guided Selection of Preoperative Chemotherapy for HER2-positive Breast Cancer: A Randomized Phase II Trial

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hys161 ◽

2012 ◽

Vol 42 (12) ◽

pp. 1211-1214 ◽

Author(s):

T. Yamaguchi ◽

H. Mukai

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preoperative Chemotherapy ◽

Phase Ii Trial ◽

Her2 Positive ◽

Ki 67 ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Selection Of ◽

Positive Breast Cancer

Download Full-text

5149 Randomized phase II trial of preoperative chemotherapy plus lapatinib, trastuzumab or both in HER2 positive breast cancer: results of the first step simon's design

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71041-9 ◽

2009 ◽

Vol 7 (2) ◽

pp. 304

Author(s):

V. Guarneri ◽

A. Frassoldati ◽

A. Bottini ◽

K. Cagossi ◽

L. Cavanna ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preoperative Chemotherapy ◽

Phase Ii Trial ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Positive Breast Cancer

Download Full-text

Abstract P4-21-03: A randomized phase II study of Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer

10.1158/1538-7445.sabcs16-p4-21-03 ◽

2017 ◽

Author(s):

M Takahashi ◽

Y Nishiyama ◽

F Hara ◽

Y Naito ◽

M Baba ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preoperative Chemotherapy ◽

Phase Ii Study ◽

Her2 Positive ◽

Ki 67 ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Positive Breast Cancer

Download Full-text

Interim Results of BACH: Randomized Phase II Trial Evaluating the Safety of Two Chemotherapy Regimens as Adjuvant Therapy in Patients with HER2-Positive Breast Cancer: PLD + Cyclophosphamide + Trastuzumab (PLD+C+H), or Doxorubicin + Cyclophosphomide (A+C), Each Followed by Paclitaxel + Trastuzumab (T+H).

10.1158/0008-5472.sabcs-09-2085 ◽

2009 ◽

Author(s):

D. Rayson ◽

T. Suter ◽

S. van der Vegt ◽

C. Jackisch ◽

A. Lluch ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Positive Breast Cancer

Download Full-text

Abstract P5-19-07: Randomized Phase II trial of afatinib alone or with vinorelbine versus investigator's choice of treatment in patients with HER2-positive breast cancer with progressive brain metastases after trastuzumab and/or lapatinib-based therapy: LUX-Breast 3

10.1158/1538-7445.sabcs14-p5-19-07 ◽

2015 ◽

Author(s):

Javier Cortés ◽

Veronique Dieras ◽

Jungsil Ro ◽

Jérôme Barriere ◽

Thomas Bachelot ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Choice Of Treatment ◽

Positive Breast Cancer

Download Full-text

Abstract OT1-1-15: LUX-Breast 3: Randomized Phase II trial of afatinib (BIBW 2992) alone or with vinorelbine versus investigator's choice of treatment in patients (pts) with HER2-positive breast cancer (BC) with progressive brain metastases after trastuzumab and/or lapatinib-based therapy*

10.1158/0008-5472.sabcs12-ot1-1-15 ◽

2012 ◽

Author(s):

H Joensuu ◽

M Ould-Kaci

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Bibw 2992 ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Choice Of Treatment ◽

Positive Breast Cancer

Download Full-text

Randomized phase II trial of preoperative lapatinib versus placebo in HER2-positive breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.576 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 576-576 ◽

Author(s):

A. De Censi ◽

M. Puntoni ◽

G. Pruneri ◽

A. Guerrieri-Gonzaga ◽

M. Cazzaniga ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Positive Breast Cancer

Download Full-text

Safety and Activity Report of a Randomized Phase II Trial of Preoperative Anthracycline-Based Chemotherapy Plus Lapatinib, Trastuzumab or Both in HER2 Positive Breast Cancer: CHERLOB Trial.

10.1158/0008-5472.sabcs-09-1093 ◽

2009 ◽

Author(s):

V. Guarneri ◽

A. Frassoldati ◽

A. Bottini ◽

K. Cagossi ◽

F. Piacentini ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Activity Report ◽

Positive Breast Cancer

Download Full-text

LAPATAX: A randomized phase II trial of FEC-docetaxel combined with lapatinib and/or trastuzumab as neoadjuvant therapy of HER2-positive breast cancer—EORTC 10054 trial.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.tps116 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. TPS116-TPS116 ◽

Author(s):

D. A. Cameron ◽

S. Marreaud ◽

K. Zaman ◽

A. Bodmer ◽

J. Pierga ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Randomized Phase Ii ◽

Positive Breast Cancer

Download Full-text

Abstract PS13-14: A randomized, opened, phase II trial assessing the efficacy and safety of ATH-TH(doxorubicin/docetaxel/trastuzumab followed by docetaxel/trastuzumab) versus TCH(docetaxel/carboplatin/trastuzumab) as neoadjuvant treatment in HER2-positive breast cancer

10.1158/1538-7445.sabcs20-ps13-14 ◽

2021 ◽

Author(s):

Tao Wang ◽

Jin-Mei Zhou ◽

Xiao-Peng Hao ◽

Hui-Qaing Zhang ◽

Shao-Hua Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Neoadjuvant Treatment ◽

Efficacy And Safety ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

Abstract P1-08-36: Neoadjuvant trial of bevacizumab (B) and trastuzumab (T) in combination with weekly paclitaxel (P) as neoadjuvant treatment in HER2-positive breast cancer: A phase II trial (AVANTHER). Analysis of biomarkers

10.1158/0008-5472.sabcs13-p1-08-36 ◽

2013 ◽

Author(s):

M Fernández ◽

N Martinez ◽

I Calvo ◽

E Garcia ◽

L Ugidos ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Neoadjuvant Treatment ◽

Weekly Paclitaxel ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text